SOURCE: Cook Pharmica LLC

October 31, 2005 08:00 ET

Cook Pharmica Is the First to Offer Webcam Services to Customers

Biotech Company Finishes Construction on $70 Million Biotech Plant

BLOOMINGTON, IN -- (MARKET WIRE) -- October 31, 2005 -- Cook Pharmica LLC, the newest Cook Group company, will be the first among its peers to offer live Webcam services via secure Internet connections to its customers.

This innovation will enable both clients and regulatory agencies to view production as it occurs to help ensure the highest levels of quality control and customer satisfaction. Cook Pharmica will also provide Webcam services to the Food and Drug Administration and its international equivalents, pending client approval.

"We are pleased to continue the Cook tradition of innovation 'firsts' with Cook Pharmica," said Cook Pharmica President Jerry Arthur. "Transparency is critical in the biopharmaceutical field. Customers need to have as much confidence in our work as they have in their own."

Cook Pharmica is one of only a few Midwest contract services manufacturers in the biopharmaceutical industry to house bioreactors for reproduction of active pharmaceutical ingredients. It houses three bioreactors, two with capacities of 2,500 liters, in addition to a 600-liter bioreactor. Cook Pharmica will also employ single-use disposable bag technology.

Arthur, a former Eli Lilly and Company employee, served as president of Cook Pharmaceutical Solutions when it became the first pharmaceutical company in the world to allow customers to watch their products being manufactured. Cook Pharmaceutical Solutions was later sold by Cook Group to Baxter Healthcare Corporation.

Cook Pharmica renovated an abandoned factory to create the 124,000-square-foot facility. At one time, the building housed the world's largest color television assembly plant. Cook Pharmica expects to employ 200 people when it begins full-scale manufacturing. Some manufacturing could begin as early as the third quarter of 2006. Eventually, the biopharmaceutical facility could house several hundred employees and occupy as much as 450,000 square feet of space.

Cook Pharmica will provide clients with a flexible, scaleable and transferable manufacturing process they can take back to their own facilities, a key competitive advantage for both Pharmica and its customers. It also can expand its manufacturing capacity to support its clients' expanding product needs.

Cook Pharmica uses state-of-the-art, integrated process control systems configured and validated at the modular level. Because of the modular and ISA S88 standard compliant architecture, recipe changes -- changes in the operation of the equipment due to different products -- do not change the core operation of the software and do not require software re-validation. This advantage allows Cook Pharmica to flexibly configure for a multitude of products.

Customers could be using Cook Pharmica's development services as early as the end of the first quarter of 2006. Manufacturing can begin as soon as the plant undergoes extensive testing to ensure that it operates as it has been designed. Equipment will be tested to ensure it produces consistent results.

Cook Pharmica completed construction on its facility in 10 months, substantially faster than the industry standard of 18-36 months.

"We are an agile, privately owned company that can make educated decisions in a short amount of time," said Roger Brunkow, Cook Pharmica director of operations. "We plan to carry this philosophy throughout our operations and begin serving customers in 2006."

The world's largest privately held manufacturer of medical devices with international headquarters in Bloomington, Ind., COOK® ( is a leading designer, manufacturer and global distributor of minimally invasive medical device technology for diagnostic and therapeutic procedures. Since its founding in 1963, Cook has created innovative technologies for drug-eluting and bare metal stents, aortic and vascular endografts, catheters, wire guides, introducer needles and sheaths, embolization coils, medical biomaterials and contract manufacturing of biopharmaceuticals, vena cava filters and other minimally invasive medical devices for radiology, cardiology, urology and OB/GYN, critical care medicine, surgery, gastroenterology, bone access and endovascular therapies.

Contact Information

  • News Media Contacts:

    David McCarty
    Director of Public Relations
    COOK Inc.
    812-339-2235, ext. 2387
    317-709-6941 (cell)
    Email Contact

    Lori Pugh
    Hirons & Company Communications
    317.409.3730 (cell)
    317.977.2206 ext. 224
    Email Contact